Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma

[1]  Di Li,et al.  Biomaterials That Induce Immunogenic Cell Death , 2023, Small methods.

[2]  M. Nierengarten.  Annual report to the nation on the status of cancer , 2022, Cancer.

[3]  Jianxun Ding,et al.  Self-Adaptive Nanomaterials for Rational Drug Delivery in Cancer Therapy , 2022, Accounts of Materials Research.

[4]  Jianxun Ding,et al.  Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis , 2022, Acta pharmaceutica Sinica. B.

[5]  Guangya Xiang,et al.  Nanoscale CaO2 materials for synergistic transarterial chemoembolization in a VX2 orthotopic rabbit liver cancer model. , 2022, Acta biomaterialia.

[6]  Tao Jiang,et al.  Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma , 2022, Journal of Nanobiotechnology.

[7]  T. Meyer,et al.  Hepatocellular carcinoma , 2022, The Lancet.

[8]  Bo Li,et al.  Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation , 2022, Bioactive materials.

[9]  Hongyun Zhao,et al.  Visualization system based on hierarchical targeting for diagnosis and treatment of hepatocellular carcinoma , 2022, Materials today. Bio.

[10]  Haw-Ming Huang,et al.  Toxicologic Concerns with Current Medical Nanoparticles , 2022, International journal of molecular sciences.

[11]  Jongpil Kim,et al.  Systematic and mechanistic analysis of AuNP-induced nanotoxicity for risk assessment of nanomedicine , 2022, Nano Convergence.

[12]  Doan Y. Dao,et al.  Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma , 2022, Nature Reviews Gastroenterology & Hepatology.

[13]  Jianxun Ding,et al.  Rational construction of polycystine-based nanoparticles for biomedical applications. , 2022, Journal of materials chemistry. B.

[14]  X. Jing,et al.  Indocyanine green potentiated paclitaxel nanoprodrugs for imaging and chemotherapy , 2022, Exploration.

[15]  Gang Liu,et al.  A clinical trial of super-stable homogeneous lipiodol-nanoICG formulation-guided precise fluorescent laparoscopic hepatocellular carcinoma resection , 2022, Journal of Nanobiotechnology.

[16]  X. Pei,et al.  Biosynthetic Gas Vesicles from Halobacteria NRC-1: A Potential Ultrasound Contrast Agent for Tumor Imaging , 2022, Pharmaceutics.

[17]  J. Si,et al.  Two-Stage Targeted Bismuthene-Based Composite Nanosystem for Multimodal Imaging Guided Enhanced Hyperthermia and Inhibition of Tumor Recurrence. , 2022, ACS applied materials & interfaces.

[18]  Junxian Liu,et al.  Superior Fluorescent Nanoemulsion Illuminates Hepatocellular Carcinoma for Surgical Navigation , 2022, Frontiers in Bioengineering and Biotechnology.

[19]  Xiangdong Xue,et al.  Stimuli‐responsive crosslinked nanomedicine for cancer treatment , 2022, Exploration.

[20]  S. Fang,et al.  HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma. , 2022, Biomaterials.

[21]  Lin Liu,et al.  Doxorubicin-Loaded UiO-66/Bi2S3 Nanocomposite-Enhanced Synergistic Transarterial Chemoembolization and Photothermal Therapy against Hepatocellular Carcinoma. , 2022, ACS applied materials & interfaces.

[22]  T. Xia,et al.  Understanding Nanomaterial–Liver Interactions to Facilitate the Development of Safer Nanoapplications , 2022, Advanced materials.

[23]  Peng Lei,et al.  Noninvasive Visualization of Sub-5 mm Orthotopic Hepatic Tumors by a Nanoprobe-Mediated Positive and Reverse Contrast-Balanced Imaging Strategy. , 2022, ACS nano.

[24]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[25]  Xiaoyao Liu,et al.  Folate-functionalized SMMC-7721 liver cancer cell membrane-cloaked paclitaxel nanocrystals for targeted chemotherapy of hepatoma , 2021, Drug delivery.

[26]  M. Bhat,et al.  Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment , 2021, Pharmaceutics.

[27]  Xuesi Chen,et al.  Smart transformable nanoparticles for enhanced tumor theranostics , 2021, Applied Physics Reviews.

[28]  Yongfang Yuan,et al.  Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma , 2021, Journal of Nanobiotechnology.

[29]  Haihua Xiao,et al.  Enhanced Chemodynamic Therapy and Chemotherapy via Delivery of a Dual Threat ArtePt and Iodo‐Click Reaction Mediated Glutathione Consumption , 2021, Small methods.

[30]  Li Xu,et al.  Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Dengfeng Li,et al.  A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma. , 2021, Journal of materials chemistry. B.

[32]  J. Marrero,et al.  GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis , 2021, Hepatology.

[33]  G. Casazza,et al.  Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. , 2021, The Cochrane database of systematic reviews.

[34]  S. Choudhury,et al.  Alpha-ketoglutarate decorated iron oxide-gold core-shell nanoparticles for active mitochondrial targeting and radiosensitization enhancement in hepatocellular carcinoma. , 2021, Materials science & engineering. C, Materials for biological applications.

[35]  Zhiqiang Yu,et al.  Integrating of lipophilic platinum(IV) prodrug into liposomes for cancer therapy on patient-derived xenograft model , 2021, Chinese Chemical Letters.

[36]  Qi Guo,et al.  Aminopeptidase N-targeting nanomolecule-assisted delivery of VEGF siRNA to potentiate antitumour therapy by suppressing tumour revascularization and enhancing radiation response. , 2021, Journal of materials chemistry. B.

[37]  R. Leblanc,et al.  The use of nanotechnology to combat liver cancer: Progress and perspectives. , 2021, Biochimica et biophysica acta. Reviews on cancer.

[38]  Ming Liu,et al.  Brefeldin A Delivery Nanomicelles in Hepatocellular Carcinoma Therapy: Characterization, Cytotoxic Evaluation In Vitro, and Antitumor Efficiency In Vivo. , 2021, Pharmacological research.

[39]  A. Jemal,et al.  Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics , 2021, Journal of the National Cancer Institute.

[40]  V. Lee,et al.  Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant , 2021, Hepatology.

[41]  R. Niessner,et al.  Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma. , 2021, Analytical chemistry.

[42]  M. Makuuchi,et al.  A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): Analysis of overall survival. , 2021 .

[43]  Zijian Zhou,et al.  Improving the sensitivity of T1 contrast-enhanced MRI and sensitive diagnosing tumors with ultralow doses of MnO octahedrons , 2021, Theranostics.

[44]  G. Casazza,et al.  Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. , 2021, The Cochrane database of systematic reviews.

[45]  S. Raman,et al.  Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[46]  Yahui Liu,et al.  Ataxia Telangiectasia Mutated Inhibitor-Loaded Copper Sulfide Nanoparticles for Low-Temperature Photothermal Therapy of Hepatocellular Carcinoma. , 2021, Acta biomaterialia.

[47]  Lixia Xu,et al.  Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent Mechanism , 2021, Hepatology.

[48]  Kun Chen,et al.  Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer. , 2021, Journal of colloid and interface science.

[49]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[50]  Y. Shiue,et al.  Pterostilbene Nanoparticles Downregulate Hypoxia-Inducible Factors in Hepatoma Cells Under Hypoxic Conditions , 2021, International journal of nanomedicine.

[51]  M. Kudo,et al.  IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC). , 2021, Journal of Clinical Oncology.

[52]  I. Khalil,et al.  Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[53]  Jin-Zhi Du,et al.  A polymeric nanoformulation improves the bioavailability and efficacy of sorafenib for hepatocellular carcinoma therapy. , 2021, Biomaterials science.

[54]  Haiyang Xie,et al.  Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy , 2021, Advanced science.

[55]  Han Wu,et al.  Nanotechnology for Hepatocellular Carcinoma: From Surveillance, Diagnosis to Management. , 2021, Small.

[56]  Y. S. Zhang,et al.  Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer , 2020, Nano Research.

[57]  Jintao Liang,et al.  Highly sensitive electrochemical aptasensor for Glypican-3 based on reduced graphene oxide-hemin nanocomposites modified on screen-printed electrode surface. , 2020, Bioelectrochemistry.

[58]  Ju Dong Yang,et al.  New advances in the diagnosis and management of hepatocellular carcinoma , 2020, BMJ.

[59]  K. Ahn,et al.  Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria: A Systemic Review and Meta-analysis. , 2020, Annals of surgery.

[60]  Y. Kong,et al.  Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study , 2020, Frontiers in Oncology.

[61]  Tae Hyun Kim,et al.  Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase trial. , 2020, Journal of hepatology.

[62]  T. Zander,et al.  Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma , 2020, Cancer Immunology, Immunotherapy.

[63]  Ming Yang,et al.  Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response , 2020, Journal for ImmunoTherapy of Cancer.

[64]  Jie Tian,et al.  A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence , 2020, ACS Nano.

[65]  Yingjie Yu,et al.  Illuminating Platinum Transportation While Maximizing Therapeutic Efficacy by Gold Nanoclusters via Simultaneous Near-Infrared-I/II Imaging and Glutathione-Scavenging. , 2020, ACS nano.

[66]  Jie Tian,et al.  A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that Inhibits Metastasis and Recurrence Combined with Immunotherapy. , 2020, ACS nano.

[67]  Mikhail G. Shapiro,et al.  Biomolecular Ultrasound Imaging of Phagolysosomal Function. , 2020, ACS nano.

[68]  Xiaowei Fang,et al.  A rational route to hybrid aptamer-molecularly imprinted magnetic nanoprobe for recognition of protein biomarkers in human serum. , 2020, Analytica chimica acta.

[69]  Qun Tang,et al.  Nanosized drug-eluting bead for transcatheter arterial chemoembolization (ND-TACE). , 2020, Journal of materials chemistry. B.

[70]  M. Kudo,et al.  Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma , 2020, Liver Cancer.

[71]  Pengfei Rong,et al.  Nanozyme-assisted sensitive profiling of exosomal proteins for rapid cancer diagnosis , 2020, Theranostics.

[72]  Meiyu Song,et al.  Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma. , 2020 .

[73]  Jinde Zhang,et al.  Biocompatible melanin based theranostic agent for in vivo detection and ablation of orthotopic micro-hepatocellular carcinoma. , 2020, Biomaterials science.

[74]  Fang Zeng,et al.  Activatable Nanocomposite Probe for Preoperative Location and Intraoperative Navigation for Orthotopic Hepatic Tumor Resection via MSOT and Aggregation-induced NIR-I/II Fluorescence Imaging. , 2020, Analytical chemistry.

[75]  E. D. De Toni,et al.  The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects , 2020, Signal Transduction and Targeted Therapy.

[76]  Yong Wang,et al.  A reduction and pH dual-sensitive nanodrug for targeted theranostics in hepatocellular carcinoma. , 2020, Biomaterials science.

[77]  Yulei N. Wang,et al.  Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. , 2020, The New England journal of medicine.

[78]  Junfa Yang,et al.  Long Non-Coding RNAs in Hepatocellular Carcinoma: Ordering of the Complicated lncRNA Regulatory Network and Novel Strategies for HCC Clinical Diagnosis and Treatment. , 2020, Pharmacological research.

[79]  Mona A Alonazi,et al.  Role of Beetroot (Beta vulgaris) Juice on Chronic Nanotoxicity of Silver Nanoparticle-Induced Hepatotoxicity in Male Rats , 2020, International journal of nanomedicine.

[80]  R. Plummer,et al.  MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial , 2020, Clinical Cancer Research.

[81]  Huan Xu,et al.  Micro/Nano Technology for Next‐Generation Diagnostics , 2020 .

[82]  A. A. Terentiev,et al.  Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK , 2020, Cancers.

[83]  T. Kimura,et al.  Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma. , 2020, Journal of hepatology.

[84]  M. Odenthal,et al.  Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma , 2020, International journal of biological sciences.

[85]  P. Liang,et al.  Chemotherapeutic Nanoparticle-Based Liposomes Enhance the Efficiency of Mild Microwave Ablation in Hepatocellular Carcinoma Therapy , 2020, Frontiers in Pharmacology.

[86]  Jin‐Ming Lin,et al.  Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer. , 2020, Analytical chemistry.

[87]  H. Samadian,et al.  Toxicological profile of lipid-based nanostructures: are they considered as completely safe nanocarriers? , 2020, Critical reviews in toxicology.

[88]  Shelly C. Lu,et al.  Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma , 2020, Hepatology.

[89]  W. Qiu,et al.  Sustained release of arsenic trioxide benefits interventional therapy on rabbit VX2 liver tumor. , 2020, Nanomedicine : nanotechnology, biology, and medicine.

[90]  D. Peiffert,et al.  Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial. , 2020, International journal of radiation oncology, biology, physics.

[91]  Ting Wang,et al.  Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels , 2020, Frontiers in Oncology.

[92]  Hongyuan Chen,et al.  H2S-activatable near-infrared afterglow luminescent probes for sensitive molecular imaging in vivo , 2020, Nature Communications.

[93]  Dexi Chen,et al.  The significance of exosomes in the development and treatment of hepatocellular carcinoma , 2020, Molecular Cancer.

[94]  Wei Liu,et al.  Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment , 2020, Theranostics.

[95]  Zhen Cheng,et al.  First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows , 2019, Nature Biomedical Engineering.

[96]  Jin Chang,et al.  An NIR-responsive mesoporous silica nanosystem for synergetic photothermal-immunoenhancement therapy of hepatocellular carcinoma. , 2019, Journal of materials chemistry. B.

[97]  T. Pawlik,et al.  Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial. , 2019, JAMA oncology.

[98]  Xiaolong Liu,et al.  Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal–Organic Framework Nanoparticles to Boost Cancer Immunotherapy , 2019, Advanced healthcare materials.

[99]  T. Berg,et al.  GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[100]  S. Zaky,et al.  Nanomedicine As A Putative Approach For Active Targeting of Hepatocellular Carcinoma. , 2019, Seminars in cancer biology.

[101]  I. Khalil,et al.  A Multifunctional Lipid-based Nanodevice for the Highly-specific Co-delivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells. , 2019, Molecular pharmaceutics.

[102]  Y. Greish,et al.  Current status of nanomaterial-based treatment for hepatocellular carcinoma. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[103]  Peter J. Richardson,et al.  Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans with Cirrhosis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[104]  W. Ran,et al.  Hepatocellular Carcinoma Growth Retardation and PD-1 Blockade Therapy Potentiation with Synthetic High-density Lipoprotein. , 2019, Nano letters.

[105]  Xinming Zhao,et al.  Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma , 2019, World journal of gastroenterology.

[106]  Y. Imai,et al.  B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial , 2019, Liver Cancer.

[107]  Katsuaki Tanaka,et al.  Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis , 2019, Hepatology.

[108]  Jie Tian,et al.  Microwave Responsive Nanoplatform via P-Selectin Mediated Drug Delivery for Treatment of Hepatocellular Carcinoma with Distant Metastasis. , 2019, Nano letters.

[109]  A. Paci,et al.  Biodegradable Pickering emulsions of Lipiodol for liver trans-arterial chemo-embolization. , 2019, Acta biomaterialia.

[110]  Xuesi Chen,et al.  Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models , 2019, Theranostics.

[111]  Jie Tian,et al.  Targeted and Multifunctional Technology for Identification between Hepatocellular Carcinoma and Liver Cirrhosis. , 2019, ACS applied materials & interfaces.

[112]  M. Kudo,et al.  Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial. , 2019, The Lancet. Oncology.

[113]  Baogang Xie,et al.  Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles , 2019, Drug delivery.

[114]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[115]  M. Ziol,et al.  Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma , 2019, Oncoimmunology.

[116]  G. Gores,et al.  GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[117]  Hong-Yu Zhang,et al.  Effects of exposure of adult mice to multi-walled carbon nanotubes on the liver lipid metabolism of their offspring. , 2018, Toxicology research.

[118]  C. Zheng,et al.  Radiopaque and uniform alginate microspheres loaded with tantalum nanoparticles for real-time imaging during transcatheter arterial embolization , 2018, Theranostics.

[119]  L. Qin,et al.  Laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 157 patients: A case controlled study with propensity score matching at two Chinese centres. , 2018, International journal of surgery.

[120]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.

[121]  Jingxian Shen,et al.  Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis , 2018, Alimentary pharmacology & therapeutics.

[122]  D. Sinn,et al.  Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications , 2018, European Radiology.

[123]  L. Yobas,et al.  Label-Free Multiplexed Electrical Detection of Cancer Markers on a Microchip Featuring an Integrated Fluidic Diode Nanopore Array. , 2018, ACS nano.

[124]  Yingchun Zhu,et al.  A redox cycling-amplified electrochemical immunosensor for α-fetoprotein sensitive detection via polydopamine nanolabels. , 2018, Nanoscale.

[125]  Gisela Schwab,et al.  Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma , 2018, The New England journal of medicine.

[126]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[127]  Rafael Duran,et al.  Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. , 2018, The lancet. Gastroenterology & hepatology.

[128]  J. Marrero,et al.  Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. , 2018, Gastroenterology.

[129]  J. Bruix,et al.  Hepatocellular carcinoma , 2018, The Lancet.

[130]  M. Kudo,et al.  Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial , 2018, The Lancet.

[131]  Xiangyang Shi,et al.  Heat shock protein-guided dual-mode CT/MR imaging of orthotopic hepatocellular carcinoma tumor. , 2018, Journal of materials chemistry. B.

[132]  Zhigang Wang,et al.  Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma , 2018, Theranostics.

[133]  Chihua Fang,et al.  Near infrared-emitting persistent luminescent nanoparticles for Hepatocellular Carcinoma imaging and luminescence-guided surgery. , 2018, Biomaterials.

[134]  C. Sirlin,et al.  Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis , 2018, Hepatology.

[135]  S. Fan,et al.  Randomized clinical trial of hepatic resection versus radiofrequency ablation for early‐stage hepatocellular carcinoma , 2017, The British journal of surgery.

[136]  Zixing Huang,et al.  Gadoxetic acid disodium–enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta‐analysis , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[137]  Z. Wang,et al.  Janus Gold Nanoplatform for Synergetic Chemoradiotherapy and Computed Tomography Imaging of Hepatocellular Carcinoma. , 2017, ACS nano.

[138]  M. Pompili,et al.  Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules. , 2017, Journal of hepatology.

[139]  Ivan Bricault,et al.  EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[140]  Junchao Duan,et al.  Silica nanoparticles induce liver fibrosis via TGF-β1/Smad3 pathway in ICR mice , 2017, International journal of nanomedicine.

[141]  B. Bay,et al.  Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T1 Magnetic Resonance Imaging Contrast Agent. , 2017, ACS nano.

[142]  Jasmin A. Tiro,et al.  An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis , 2017, Hepatology.

[143]  Mingwu Shen,et al.  Targeted CT/MR dual mode imaging of human hepatocellular carcinoma using lactobionic acid-modified polyethyleneimine-entrapped gold nanoparticles. , 2017, Journal of materials chemistry. B.

[144]  Zhigang Wang,et al.  Low-intensity focused ultrasound (LIFU)-induced acoustic droplet vaporization in phase-transition perfluoropentane nanodroplets modified by folate for ultrasound molecular imaging , 2017, International journal of nanomedicine.

[145]  Masatoshi Kudo,et al.  Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial , 2017, The Lancet.

[146]  Ian D. McGilvray,et al.  Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[147]  Steffen Loft,et al.  Nanomaterial translocation–the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs–a review , 2015, Critical reviews in toxicology.

[148]  T. Vogl,et al.  Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study , 2009, CardioVascular and Interventional Radiology.

[149]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[150]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[151]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[152]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[153]  S. Kawasaki,et al.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. , 2003, Journal of hepatology.

[154]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[155]  J. Bruix,et al.  Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.

[156]  S. Nagataki,et al.  Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. , 1993, The New England journal of medicine.

[157]  Dr. Ron Short.  Diagnosis? , 1987, The Lancet.

[158]  Shou-Dong Lee,et al.  Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma , 1984 .

[159]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[160]  Zhu Haidong,et al.  A biodegradable multifunctional porous microsphere composed of carrageenan for promoting imageable trans-arterial chemoembolization. , 2019, International journal of biological macromolecules.

[161]  Yoon-Koo Kang,et al.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. , 2009, The Lancet. Oncology.

[162]  N. Dubrawsky.  Cancer statistics , 2022 .